Australia's Healius eyes best week in 3 months on strategic review, CEO change

Healius

08/03/2024 01:01

** Shares of Healius Ltd  HLS.AX  have gained 13% so far
this week; set for best weekly gain since Dec. 1, if trend holds
    ** Healthcare firm on Tuesday said it would start a review 
and engage investment advisers, after regulator rejected a $1
bln takeover by Australian Clinical Labs  ACL.AX  last year
    ** Co also announced change in CEO to lead the strategic
review
    ** Co said proceeds from the sale will increase its CET1
ratio by 16 basis points
    ** Stock up as much as 3.1% at A$1.35 on the day
    ** Stock down 19.9% YTD, as of last close 
 

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))